Page last updated: 2024-09-05

tetraphenylphosphonium and Cardiomyopathies

tetraphenylphosphonium has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjork, JA; Froberg, MK; Leino, RL; Moreno, AJ; Oliveira, PJ; Santos, MS; Wallace, KB1

Other Studies

1 other study(ies) available for tetraphenylphosphonium and Cardiomyopathies

ArticleYear
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
    Toxicology and applied pharmacology, 2004, Oct-15, Volume: 200, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Antibiotics, Antineoplastic; Antioxidants; Calcium; Carbazoles; Cardiomyopathies; Carvedilol; Cell Surface Extensions; Doxorubicin; Glutathione Peroxidase; Glutathione Reductase; Ion Channels; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Onium Compounds; Organophosphorus Compounds; Oxygen Consumption; Propanolamines; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase

2004